138 related articles for article (PubMed ID: 3965374)
41. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Kauppila A
Acta Obstet Gynecol Scand; 1984; 63(5):441-50. PubMed ID: 6238499
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
Holinka CF; Deligdisch L; Deppe G; Fleming H; Namit C; de la Pena MM; Gurpide E
Adv Exp Med Biol; 1981; 138():365-76. PubMed ID: 6211063
[No Abstract] [Full Text] [Related]
43. Progestin therapy for perimenopausal women.
Kase NG
J Reprod Med; 1982 Aug; 27(8 Suppl):522-30. PubMed ID: 7131445
[No Abstract] [Full Text] [Related]
44. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
[TBL] [Abstract][Full Text] [Related]
45. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
46. Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma.
Mortel R; Zaino R; Satyaswaroop PG
Cancer; 1984 Jan; 53(1):113-6. PubMed ID: 6689993
[TBL] [Abstract][Full Text] [Related]
47. [Cytoplasmic steroid hormone receptors in the tumors of endometrial cancer patients].
Kuz'mina ZV; Bassalyk LS; Murav'eva NI; Peskova VI; Ermilova VD
Akush Ginekol (Mosk); 1984 Apr; (4):29-32. PubMed ID: 6742345
[No Abstract] [Full Text] [Related]
48. The effectiveness of medroxyprogesterone in the treatment of multiple metastasizing leiomyosarcomas: report of a case.
Uchida T; Nakakawaji K; Sakamoto J; Kojima H; Murakami H; Kato J; Yasue M
Surg Today; 1996; 26(2):138-41. PubMed ID: 8919287
[TBL] [Abstract][Full Text] [Related]
49. Benign metastasizing leiomyoma responsive to megestrol: case report and review of the literature.
Wentling GK; Sevin BU; Geiger XJ; Bridges MD
Int J Gynecol Cancer; 2005; 15(6):1213-7. PubMed ID: 16343217
[TBL] [Abstract][Full Text] [Related]
50. Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy?
Benraad TJ; Friberg LG; Koenders AJ; Kullander S
Acta Obstet Gynecol Scand; 1980; 59(2):155-9. PubMed ID: 7405552
[TBL] [Abstract][Full Text] [Related]
51. Estradiol and progesterone receptors in normal and neoplastic endometrium: correlations between receptors, histopathological examinations and clinical responses under progestin therapy.
Martin PM; Rolland PH; Gammerre M; Serment H; Toga M
Int J Cancer; 1979 Mar; 23(3):321-9. PubMed ID: 437916
[No Abstract] [Full Text] [Related]
52. Progestin action and progesterone receptors in breast cancer.
Chamness GC
Cancer Res; 1989 Dec; 49(24 Pt 1):7176-9. PubMed ID: 2582458
[No Abstract] [Full Text] [Related]
53. Plasminogen activator activity in human endometrial carcinoma.
Whitney CW; Satyaswaroop PG; Mortel R
Gynecol Oncol; 1985 Sep; 22(1):97-104. PubMed ID: 3160638
[TBL] [Abstract][Full Text] [Related]
54. [Hormonal therapy of endometrial cancer].
Kato J
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1182-8. PubMed ID: 4057575
[TBL] [Abstract][Full Text] [Related]
55. Progestin therapy for breast cancer: a panel discussion.
McGuire WL; Cavalli F; Bonomi P; Alexieva-Figussch J
Breast Cancer Res Treat; 1985; 6(3):213-20. PubMed ID: 4092098
[TBL] [Abstract][Full Text] [Related]
56. Hormonal therapy of gynecologic cancers.
Durant JR
Semin Oncol; 1983 Dec; 10(4 Suppl 4):29-33. PubMed ID: 6669987
[TBL] [Abstract][Full Text] [Related]
57. Estrogen and progesterone receptors in leiomyomas and normal uterine tissues during reproductive life.
Marelli G; Codegoni AM; Bizzi A
Acta Eur Fertil; 1989; 20(1):19-22. PubMed ID: 2781983
[TBL] [Abstract][Full Text] [Related]
58. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
59. Estrogen and progesterone receptors in epithelial ovarian malignancies.
Sutton GP; Senior MB; Strauss JF; Mikuta JJ
Gynecol Oncol; 1986 Feb; 23(2):176-82. PubMed ID: 3943759
[TBL] [Abstract][Full Text] [Related]
60. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
